198 related articles for article (PubMed ID: 33813036)
1. Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy.
Kosoy R; Kim-Schulze S; Rahman A; Friedman JR; Huang R; Peters LA; Amir EA; Perrigoue J; Stojmirovic A; Song WM; Ke H; Ungaro R; Mehandru S; Cho J; Dubinsky M; Curran M; Brodmerkel C; Schadt EE; Sands BE; Colombel JF; Kasarskis A; Argmann CA; Suárez-Fariñas M
Cell Mol Gastroenterol Hepatol; 2021; 12(2):599-632. PubMed ID: 33813036
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
[TBL] [Abstract][Full Text] [Related]
3. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
[TBL] [Abstract][Full Text] [Related]
5. Targeted
Notararigo S; Martín-Pastor M; Viñuela-Roldán JE; Quiroga A; Dominguez-Munoz JE; Barreiro-de Acosta M
J Mol Med (Berl); 2021 Sep; 99(9):1251-1264. PubMed ID: 34021361
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease.
Lord JD; Shows DM
World J Gastroenterol; 2017 May; 23(18):3240-3251. PubMed ID: 28566883
[TBL] [Abstract][Full Text] [Related]
7. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
[TBL] [Abstract][Full Text] [Related]
8. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
Clarke K; Chintanaboina J
Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
[TBL] [Abstract][Full Text] [Related]
9. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.
Funderburg NT; Stubblefield Park SR; Sung HC; Hardy G; Clagett B; Ignatz-Hoover J; Harding CV; Fu P; Katz JA; Lederman MM; Levine AD
Immunology; 2013 Sep; 140(1):87-97. PubMed ID: 23600521
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapies for inflammatory bowel disease.
Zenlea T; Peppercorn MA
World J Gastroenterol; 2014 Mar; 20(12):3146-52. PubMed ID: 24696600
[TBL] [Abstract][Full Text] [Related]
12. Serum tumor necrosis factor activity in inflammatory bowel disease.
Maeda M; Watanabe N; Neda H; Yamauchi N; Okamoto T; Sasaki H; Tsuji Y; Akiyama S; Tsuji N; Niitsu Y
Immunopharmacol Immunotoxicol; 1992; 14(3):451-61. PubMed ID: 1517530
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.
Kattah MG; Milush JM; Burt T; McCabe RP; Whang MI; Ma A; Mahadevan U
Clin Transl Gastroenterol; 2018 Apr; 9(4):143. PubMed ID: 29618720
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
[TBL] [Abstract][Full Text] [Related]
17. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
[TBL] [Abstract][Full Text] [Related]
18. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
19. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
